Su1843: SAFETY OF GUSELKUMAB IN INFLAMMATORY BOWEL DISEASE UP TO 1 YEAR: INTEGRATED SAFETY ANALYSIS OF PHASE 2 AND 3 STUDIES IN CROHN’S DISEASE AND ULCERATIVE COLITIS | Publicación